A61P 7 - Drugs for disorders of the blood or the extracellular fluid

Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
11/2009
11/25/2009	CN101584859A Orally-taken hirudin microsphere preparation and preparation method thereof
11/25/2009	CN101584778A Tibetan medicine for clearing blood, nourishing veins and enhancing blood circulation and preparation method thereof
11/25/2009	CN101584774A Application of compound thrombus-invigorating capsule for preparation of medicament for treating cerebrovascular disease
11/25/2009	CN101584740A Traditional Chinese medical composition capable of tonifying Qi of the kidney, nourishing blood and promoting blood circulation, and a preparation method thereof
11/25/2009	CN101584700A Pharmaceutical composition
11/25/2009	CN101584687A Application of alfa-ketoglutaric acid iron in preparing iron-filling drug and health care product
11/25/2009	CN101584683A Metolazone slow-release capsule and method for preparing same
11/25/2009	CN101584682A Rutin-arabic-gum-gelatin slowreleasing microspheres and preparation thereof
11/25/2009	CN101584680A Tablet capsule containing clopidogrel hydrogen sulfate salt tablets and acetylsalicylic acid tablets
11/25/2009	CN101584670A Decitabine freeze-dried powder injection
11/25/2009	CN101584368A Health tea for clearing heat and promoting blood circulation of middle-aged people
11/25/2009	CN100562330C The Chinese traditional medicinal powder for hemostasia, acesodyne, myogenic, sore, healing and its preparation method
11/25/2009	CN100562309C Injectable composition of clopidogrel and its salt and preparation method thereof
11/24/2009	US7622474 Asulfonyl(urea, thiourea, guanidine, cyanoguanidine) compounds; cardiovascular disorders; thrombosis
11/24/2009	US7622471 Pyrazole derivatives having a pyridazine and pyridine functionality
11/24/2009	US7622457 Polynucleotides encoding anticoagulant fusion proteins
11/24/2009	US7622439 Method to enhance hemodynamic stability using oxygen carrying compositions
11/24/2009	US7622122 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome; targeting protein, that interacts with tissue factor or the factor VIIa/tissue factor complex
11/24/2009	CA2552786C Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
11/24/2009	CA2475712C Nicotinamide derivatives useful as pde4 inhibitors
11/24/2009	CA2415383C New amidino derivatives and their use as thrombin inhibitors
11/24/2009	CA2413337C Bioadhesive compositions and methods of preparation and use
11/24/2009	CA2373859C Blood carbonyl compound-trapping agent
11/24/2009	CA2256391C Anticoagulant peptidyl-arginine aldehyde derivatives
11/24/2009	CA2203182C Remedy for diseases caused by il-6 production
11/19/2009	WO2009139822A1 Anti-hepcidin antibodies and methods of use
11/19/2009	WO2009139373A1 Amide compound
11/19/2009	WO2009139361A1 Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group
11/19/2009	WO2009138796A2 Substituted quinazolines
11/19/2009	WO2009138795A1 Substituted quinazolines
11/19/2009	WO2009138794A1 Imidazoquinazoline derivatives as anagrelide analogues for the treatment of myeloprolific diseases and thrombotic diseases
11/19/2009	WO2009138793A1 Substituted quinazolines as blood platelet lowering agents
11/19/2009	WO2009138792A1 Substituted quinazolines
11/19/2009	WO2009138791A1 2h- pyrimido [2, 1-b] quinaz0lin-2-0ne derivatives and their use as platelet anti-aggregative agents
11/19/2009	WO2009138790A1 Substituted quinazolines and their uses for myeoloprolific and thrombotic diseases
11/19/2009	WO2009138789A1 Substituted quinazolines as blood platelet lowering agents
11/19/2009	WO2009138788A1 Substituted quinazolines
11/19/2009	WO2009138761A1 Mono ( iron hydroxypyrone ) and combination ( iron hydroxypyrone and gi inflammation inhibiting agents ) compositions for anaemia or h. pylori infections
11/19/2009	WO2009138176A1 Substituted imidazo- and triazolopyrimidines, imidazo- and pyrazolopyrazines and imidazotriazines as gsk3beta-inhibitors
11/19/2009	WO2009079910A8 An erythropoietin mimetic peptide derivatives and its pharmaceutical salt, the preparation and uses thereof
11/19/2009	US20090286881 Selected betaines and their uses
11/19/2009	US20090286852 RNA containing modified nucleosides and methods of use thereof
11/19/2009	US20090286799 Methods for the treatment of brain edema
11/19/2009	US20090286761 Anti-Proliferative and Anti-Inflammatory Agent Combination for Treatment of Vascular Disorders with an Implantable Medical Device
11/19/2009	US20090286736 using polypeptide comprising a membrane translocation domain and a NF- kappa B Essential Modulator (NEMO) binding sequence; comprising a NEMO binding domain (NBD)
11/19/2009	US20090286721 Targeted plasminogen activator fusion proteins as thromobolytic agents
11/19/2009	US20090286720 Pharmaceutical composition for the diagnosis, prevention or treatment of a tumoral pathology comprising an agent modulating the polymerization state of actin
11/19/2009	US20090286713 Collagen Receptor I-Domain Binding Modulators
11/19/2009	US20090285816 Albumin Fusion Proteins
11/19/2009	US20090285793 Thrombinase having a molecular weight of 31,000 to 32,000; used for dissolving blood clots; culturing a filtrate of Bacillus sphaericus sero type H5a 5b; filtration, salting out the retentate, decolourizing, purifying and dialyzing.
11/19/2009	CA2724470A1 Maintenance of platelet inhibition during antiplatelet therapy
11/19/2009	CA2724216A1 2h- pyrimido [2, 1-b] quinazolin-2-one derivatives and their use as platelet anti-aggregative agents
11/19/2009	CA2724213A1 Substituted quinazolines as blood platelet lowering agents
11/19/2009	CA2724181A1 Imidazoquinazoline derivatives as anagrelide analogues for the treatment of myeloprolific diseases and thrombotic diseases
11/19/2009	CA2724180A1 Substituted quinazolines
11/19/2009	CA2724172A1 Mono ( iron hydroxypyrone ) and combination ( iron hydroxypyrone and gi inflammation inhibiting agents ) compositions for anaemia or h. pylori infections
11/19/2009	CA2724077A1 Amide compound
11/19/2009	CA2724055A1 Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2 -dihydroquinoline derivatives having substituted oxy group
11/19/2009	CA2724035A1 Substituted quinazolines
11/19/2009	CA2724020A1 Substituted quinazolines and their uses for myeoloprolific and thrombotic diseases
11/19/2009	CA2723958A1 Substituted quinazolines
11/19/2009	CA2723858A1 Substituted quinazolines
11/19/2009	CA2723857A1 Substituted quinazolines
11/19/2009	CA2722600A1 Anti-hepcidin antibodies and methods of use
11/18/2009	EP2119443A1 Composition for prevention or treatment of disease associated with thrombus or embolus
11/18/2009	EP2119438A1 Bone metabolism ameliorating agent
11/18/2009	EP2117561A1 Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines
11/18/2009	EP1490064B1 Substituted pyridinones as modulators of p38 map kinase
11/18/2009	EP1458425B1 A hemostatic kit, a method of preparing a hemostatic agent and a method of promoting hemostasis
11/18/2009	EP1442026B9 Triazole derivatives as cyclooxygenase (cox) inhibitors
11/18/2009	EP1292671B1 Method for obtaining characterised muscle-derived cell populations and uses
11/18/2009	EP0760811B1 Imidazole derivatives as histamine receptor h3 modulators
11/18/2009	CN101580547A HASylated polypeptides, especially HASylated erythropoietin
11/18/2009	CN101580497A Statins antilipemic drugs furazan nitroxides derivates and preparation method thereof
11/18/2009	CN101579505A Restorative preparation and preparation method thereof
11/18/2009	CN101579502A Wormwood strip containing natural aromatic plants
11/18/2009	CN101579499A Traditional Chinese medicine for treating urinary incontinence
11/18/2009	CN101579493A Donkey-hide gelatin paste of traditional Chinese medicine
11/18/2009	CN101579461A Traditional Chinese medicine for curing diabetes insipidus
11/18/2009	CN101579453A Veterinary drug injection for treating hydropsy for baby pigs and preparation method thereof
11/18/2009	CN101579440A Traditional Chinese medicine preparation used for thrombocytopenia and leukopenia
11/18/2009	CN101579360A Application of high-activity leeches animal extractive in preparing medicament and preparation method of high-activity leeches animal extractive
11/18/2009	CN101579356A Deproteinated calf blood ingredient brain targeting nanosphere and preparation method thereof
11/18/2009	CN101579354A Application of chitosan in preparing drugs for preventing and curing bacterial septicemia of silkworm
11/18/2009	CN101579337A Clopidogrel composition and preparation method thereof
11/18/2009	CN100561229C A cytocapacity test
11/18/2009	CN100560094C Preparing art of cassia twig and Tuckahoe composition and use thereof
11/18/2009	CN100560092C Externally used traditional Chinese medicine for treating hepatitis B and hepatic ascites
11/17/2009	US7619082 Process for the preparation of 3-spiro′cyclohexan-1,3′-′3H!indolin-2′-one! derivatives
11/17/2009	US7619001 Utilization of dialkylfumarates
11/17/2009	US7618955 Association of an antithrombotic and aspirin
11/17/2009	US7618657 For increasing hemoglobin expression level, reactivating fetal or adult hemoglobin, inducing gamma -globin, stimulating cell differentiation, inhibiting malignant cell proliferation, or treating a hemoglobinopathy or a malignant disease
11/17/2009	US7618652 Glycosaminoglycan anticoagulants derived from fish
11/17/2009	US7618629 Manipulation of cytokine levels using CD83 gene products
11/17/2009	US7618628 CD16A binding proteins and use for the treatment of immune disorders
11/17/2009	US7618584 That are blood, bone marrow or umbilical cord blood; parts of the bag system are connected to form a closed, sterile system before the bag system is used; storage regions are hermetically sealable and separable from one another
11/17/2009	CA2535511C Compounds having thrombopoietin receptor agonism
11/17/2009	CA2393809C Heterocyclic dihydropyrimidines as potassium channel inhibitors
11/17/2009	CA2374158C Indole derivatives
11/17/2009	CA2369997C Compositions and methods for treating amyloidosis

1 ... 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 ... 671